GlaxoSmithKline Pharmaceuticals Ltd. is a large-cap pharmaceutical company with a market capitalization of 25,764 crores. The corporation manufactures a wide variety of pharmaceutical drugs, vaccines, and is one of the best known pharmaceutical products. for the purpose of total dividend of 150, the company has fixed 8 July 2022 as the record date.
The company in a BSE exchange filing said that “The Board has recommended a dividend of Rs.90/- (including special dividend of Rs.60) at a face value of Rs.10 per equity share for the year ended March 31, 2022, Subject to the approval of the members at the 97th Annual General Meeting to be held on Tuesday, July 26, 2022. In accordance with Regulation 42 of the SEBI (Listed Liabilities and Disclosure Requirements) Regulations, 2015, the Company has declared the final dividend for the financial year ended 31st July, 2022. Friday, July 8, 2022, has been fixed as the record date for determining the eligibility of the members. March, 2022. The dividend shall be paid on or after Wednesday, July 27, 2022, if approved by the members.”
The stock ended Friday’s trading session at a market price of Rs. 1,506.25, up 0.41 percent from its previous close 1500.15. The stock is down 1.91 percent in the past year, and has fallen 13.29 percent so far in 2022 on a year-on-year (YTD) basis. Shares of GlaxoSmithKline Pharmaceuticals Ltd have fallen 12.81 per cent in the last six months and 2.34 per cent in the last month. The stock has lost 2.47 per cent in the last five trading days. GlaxoSmithKline Pharmaceuticals Ltd shares hit 52-week high 52-week low of 1,918.75 on December 13, 2021 and 1,450.00 on October 25, 2021, indicating that the stock is now trading 21% below its 52-week high and 3.87 percent above its 52-week low. The stock is trading below the 5-day, 20-day, 50-day, 100-day and 200-day moving averages as per the latest trading price.